Skip to main content
Equibles
VRDN logo

VRDN · Viridian Therapeutics, Inc.\DE

Track VRDN — free

Use VRDN with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about VRDN

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$22.08 +0.09 (+0.41%) At close · Aug 14
Market Cap
$2.50B
Shares
113.29M

Viridian Therapeutics, Inc.\DE Earnings Call Transcripts

Every quarterly earnings call for Viridian Therapeutics, Inc.\DE (VRDN) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲84.9% $880,000 −$10.12M '19 Q4 20-03-11 ▲122.6% $828,000 −$8.04M '20 Q1 20-05-07 ▼93.3% $168,000 −$6.43M '20 Q2 20-08-05 ▼93.9% $54,000 −$90.74M '20 Q4 21-03-25 ▲296.3% $214,000 −$28.95M '21 Q4 22-03-10 ▼85.1% $216,000 −$25.69M '22 Q1 22-05-12 ▼76.5% $256,000 −$29.49M '22 Q2 22-08-15 ▼50.9% $105,000 −$45.78M '22 Q4 23-03-08 ▼54.6% $98,000 −$68.15M '23 Q1 23-05-09 ▼94% $72,000 −$47.66M '23 Q3 23-11-13 ▼26.5% $72,000 −$48.54M '24 Q1 24-05-08 ▲0% $72,000 −$79.72M '24 Q4 25-02-27 ▲0% $72,000 −$86.91M '25 Q1 25-05-06 ▲81958.1% $70.57M −$34.60M '25 Q3 25-11-05 ▲83.3% $132,000 −$120.36M '25 Q4 26-02-26 LATEST ▲95.8% $141,000 −$104.90M '26 Q1 26-05-05
Conference
Investor event
2026-06-09
Goldman Sachs 47th Annual Global Healthcare Conference
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-06-03
Jefferies Global Healthcare Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-05
Viridian Therapeutics, Inc.DE Q1 FY2026 Earnings Call
Revenue
$141,000
▲ 95.8% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-26
Viridian Therapeutics, Inc.DE Q4 FY2025 Earnings Call
Revenue
$132,000*
▲ 83.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-05
Viridian Therapeutics, Inc.DE Q3 FY2025 Earnings Call
Revenue
$70.57M
▲ 81958.1% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-06
Viridian Therapeutics, Inc.DE Q1 FY2025 Earnings Call
Revenue
$72,000
▲ 0% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-27
Viridian Therapeutics, Inc.DE Q4 FY2024 Earnings Call
Revenue
$72,000*
▲ 0% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q1
2024-05-08
Viridian Therapeutics, Inc.DE Q1 FY2024 Earnings Call
Confident tone TED market opportunity FcRn portfolio (006, 008) 001 IV program / BLA timeline
Revenue
$72,000
▼ 26.5% YoY
Diluted EPS
$-0.79
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q3
2023-11-13
Viridian Therapeutics, Inc.DE Q3 FY2023 Earnings Call
Revenue
$72,000
▼ 94% YoY
Diluted EPS
$-1.09
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-09
Viridian Therapeutics, Inc.DE Q1 FY2023 Earnings Call
Revenue
$98,000
▼ 54.6% YoY
Diluted EPS
$-1.61
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-08
Viridian Therapeutics, Inc.DE Q4 FY2022 Earnings Call
Revenue
$105,000*
▼ 50.9% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q2
2022-08-15
Viridian Therapeutics, Inc.DE Q2 FY2022 Earnings Call
Revenue
$256,000
▼ 76.5% YoY
Diluted EPS
$-1.06
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-12
Viridian Therapeutics, Inc.DE Q1 FY2022 Earnings Call
Revenue
$216,000
▼ 85.1% YoY
Diluted EPS
$-0.98
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-10
Viridian Therapeutics, Inc.DE Q4 FY2021 Earnings Call
Revenue
$214,000*
▲ 296.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q4
2021-03-25
Viridian Therapeutics, Inc.DE Q4 FY2020 Earnings Call
Revenue
$54,000*
▼ 93.9% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q2
2020-08-05
Viridian Therapeutics, Inc.DE Q2 FY2020 Earnings Call
Revenue
$168,000
▼ 93.3% YoY
Diluted EPS
$-1.82
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-07
Viridian Therapeutics, Inc.DE Q1 FY2020 Earnings Call
Revenue
$828,000
▲ 122.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-03-11
Viridian Therapeutics, Inc.DE Q4 FY2019 Earnings Call
Revenue
$880,000
▲ 84.9% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–18 of 18 earnings calls
Key facts CIK 1590750 CUSIP 92790C104 13F (30d) 210 filings 205 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)